Ajooni Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 194.8 million compared to INR 102.91 million a year ago. Revenue was INR 197.7 million compared to INR 102.95 million a year ago. Net income was INR 4.05 million compared to INR 1.55 million a year ago. Basic earnings per share from continuing operations was INR 0.23 compared to INR 0.032 a year ago. Diluted earnings per share from continuing operations was INR 0.23 compared to INR 0.032 a year ago.
For the six months, sales was INR 404.83 million compared to INR 226.02 million a year ago. Revenue was INR 408.45 million compared to INR 226.13 million a year ago. Net income was INR 8.07 million compared to INR 4.77 million a year ago. Basic earnings per share from continuing operations was INR 0.46 compared to INR 0.096 a year ago. Diluted earnings per share from continuing operations was INR 0.46 compared to INR 0.096 a year ago.